cT1N0浸润性小叶癌腋窝淋巴结升级:SOUND试验结果适用性评估
结果显示17.7%患者存在腋窝淋巴结转移,仅2.3%为广泛转移,与SOUND和INSEMA试验SLNB组报告的转移率相近;脉管侵犯是唯一独立预测淋巴结阳性的因素。
要点
- 符合SOUND条件的cT1N0浸润性小叶癌患者腋窝淋巴结转移率为17.7%,广泛转移仅2.3%。
- 该转移率与SOUND试验(13.7%)和INSEMA试验(15.1%)SLNB组报告的数据相当。
- 脉管侵犯是唯一独立预测淋巴结阳性的因素,高级别和绝经前状态在单变量分析中相关。
核心结论
- 在符合SOUND试验条件的cT1N0、HR+/HER2-纯浸润性小叶癌患者中,腋窝淋巴结转移率为17.7%,广泛转移率为2.3%,与SOUND和INSEMA试验SLNB组报告的数据相当。
主要发现
- 淋巴结阳性患者更年轻、绝经前比例更高(36% vs. 26%,P=0.035),病理肿瘤更大(pT2-3占46.7% vs. 18.3%,P<0.001),脉管侵犯更常见(19% vs. 3.2%,P<0.001)。
- 单变量分析中,绝经前状态、高级别和脉管侵犯与淋巴结阳性独立相关;多变量分析中仅脉管侵犯保持独立相关。
关键数值与推荐
- SOUND试验SLNB组淋巴结阳性率为13.7%,INSEMA试验为15.1%。
- 脉管侵犯与淋巴结阳性独立相关(多变量分析)。
临床怎么用
- 对于cT1N0、HR+/HER2-纯浸润性小叶癌且腋窝超声正常的患者,可参考SOUND试验结果考虑省略前哨淋巴结活检,但需注意脉管侵犯等高风险特征。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 未报告无病生存或总生存等结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether sentinel lymph node biopsy (SLNB) omission is applicable to stage 1 invasive lobular breast cancer (ILC). BACKGROUND: The SOUND and INSEMA randomized controlled trials demonstrated that SLNB omission is noninferior to performing SLNB in early-stage, clinically node-negative (cT1-2N0), hormone receptor-positive/HER2-negative (HR+/HER2-) patients with breast cancer with negative preoperative axillary ultrasound. However, the applicability of SLNB omission in ILC has been uncertain. METHODS: We retrospectively identified patients with cT1N0, HR+/HER2- pure ILC, and normal axillary ultrasound who underwent upfront surgery with SLNB between 2009 and 2024. Clinicopathologic characteristics and pathologic nodal burden were evaluated. RESULTS: Six hundred thirty-nine patients met the inclusion criteria, of whom the majority were postmenopausal women (72%) with low- to intermediate-grade (88%) and/or classic-type (84%) ILC. Axillary nodal metastases were identified on surgical pathology in 113 (17.7%) patients: 24 (3.8%) pN1mic, 74 (11.6%) pN1, 8 (1.2%) pN2, and 7 (1.1%) pN3. Node-positive patients were more often younger, premenopausal (36% vs. 26%, P=0.035), and presented with larger pathologic tumor size (46.7% vs. 18.3% pT2-3, P<0.001) and lymphovascular invasion (LVI) (19% vs. 3.2%, P<0.001). On univariate analysis, premenopausal status, high grade, and LVI were independently associated with nodal positivity. On multivariate analysis, only LVI remained independently associated with nodal positivity. CONCLUSIONS: Among patients with SOUND-eligible ILC, 17.7% had axillary nodal metastasis and only 2.3% had extensive axillary nodal metastasis. These findings are comparable to the node-positive rates reported in the SLNB arm of the SOUND (13.7%) and INSEMA (15.1%) trials. High-risk features such as LVI and high grade were associated with nodal positivity.
引用
- Amburn T, Mamtani A, Chen JJ, et al. Axillary Nodal Upstaging in cT1N0 Invasive Lobular Carcinoma: Evaluating Applicability of SOUND Trial Results. Ann Surg. 2026. PMID: 42802378. doi:10.1097/SLA.0000000000007227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。